WVE Wave Life Sciences, Inc.
Healthcare · Market cap: $616.8M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $170.6K |
| 2022-Q2 | $20.4M | $142.4K |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $240.7K |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $176.0K |
| 2023-Q4 | $21.5M | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $96.4K |
| 2024-Q3 | $22.3M | $433.9K |
| 2024-Q4 | $0 | $6.3M |
| 2025-Q1 | $0 | $1.7M |
| 2025-Q2 | $0 | $208.5K |
| 2025-Q3 | $0 | $2.6M |
| 2025-Q4 | $27.9M | $14.9M |
| 2026-Q1 | $54.6M | $907.7K |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $135.1K |
| 2026-Q4 | $0 | $0 |
Bought$146.8M9 buy days
Sold$28.0M52 sell days
Net insider flow+$118.8Mnet buying · 5 years
Latest trade2026-08-12Rawcliffe Adrian
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-08-12 | Sell | Rawcliffe Adrian | Director | 12,700 | $5.29 | $67.2K | 1 |
| 2026-08-11 | Sell | Wagner Heidi L | Director | 7,000 | $6.01 | $42.1K | 1 |
| 2026-08-11 | Sell | TAKANASHI KEN | Director | 3,864 | $6.01 | $23.2K | 1 |
| 2026-08-11 | Sell | Tan Aik Na | Director | 432 | $6.01 | $2.6K | 1 |
| 2026-03-30 | Buy | Kolchinsky Peter | Director | 971,091 | $6.50 | $6.3M | 1 |
| 2026-03-27 | Buy | Kolchinsky Peter | Director | 2,495,623 | $6.43 | $16.0M | 1 |
| 2026-03-26 | Buy | Kolchinsky Peter | Director | 5,305,782 | $6.08 | $32.3M | 2 |
| 2026-02-26 | Sell | Francis Chris | Other officer | 33,194 | $15.05 | $499.5K | 2 |
| 2026-02-09 | Sell | BOLNO PAUL | CEO | 10,480 | $13.45 | $141.0K | 1 |
| 2026-02-09 | Sell | Moran Kyle | CFO | 3,588 | $13.45 | $48.3K | 1 |
| 2026-02-09 | Sell | Vargeese Chandra | Other officer | 3,228 | $13.45 | $43.4K | 1 |
| 2026-02-09 | Sell | Francis Chris | Other officer | 1,883 | $13.45 | $25.3K | 1 |
| 2026-01-02 | Sell | Francis Chris | Other officer | 9,375 | $16.03 | $150.3K | 2 |
| 2025-12-11 | Buy | GSK plc | 10% owner | 1,470,000 | $19.00 | $27.9M | 1 |
| 2025-12-09 | Sell | Moran Kyle | CFO | 50,036 | $20.03 | $1.0M | 2 |
| 2025-12-08 | Sell | Francis Chris | Other officer | 441,031 | $14.58 | $6.4M | 9 |
| 2025-12-08 | Sell | Moran Kyle | CFO | 210,000 | $14.77 | $3.1M | 4 |
| 2025-12-08 | Sell | Tan Aik Na | Director | 113,218 | $13.74 | $1.6M | 7 |
| 2025-12-08 | Sell | HENRY CHRISTIAN O | Director | 93,445 | $14.65 | $1.4M | 4 |
| 2025-12-08 | Sell | Rawcliffe Adrian | Director | 42,000 | $15.00 | $630.0K | 1 |
| 2025-12-08 | Sell | Verdine Gregory L. | Director | 20,000 | $13.47 | $269.5K | 2 |
| 2025-12-08 | Sell | CORRIGAN MARK | Director | 16,115 | $13.49 | $217.3K | 2 |
| 2025-12-08 | Sell | Wagner Heidi L | Director | 14,000 | $13.50 | $189.0K | 2 |
| 2025-11-13 | Sell | Rawcliffe Adrian | Director | 16,115 | $6.79 | $109.4K | 1 |
| 2025-11-13 | Buy | Kolchinsky Peter | Director | 1,000 | $6.69 | $6.7K | 1 |
| 2025-08-22 | Sell | BOLNO PAUL | CEO | 217,351 | $10.10 | $2.2M | 1 |
| 2025-08-22 | Sell | Verdine Gregory L. | Director | 10,000 | $10.00 | $100.0K | 1 |
| 2025-08-15 | Sell | Tan Aik Na | Director | 21,000 | $9.25 | $194.2K | 1 |
| 2025-08-13 | Sell | HENRY CHRISTIAN O | Director | 9,670 | $8.81 | $85.2K | 1 |
| 2025-08-05 | Sell | TAKANASHI KEN | Director | 4,872 | $8.75 | $42.6K | 1 |
| 2025-08-05 | Sell | Tan Aik Na | Director | 1,127 | $8.75 | $9.9K | 1 |
| 2025-06-13 | Sell | Verdine Gregory L. | Director | 30,000 | $6.95 | $208.5K | 1 |
| 2025-03-20 | Sell | HENRY CHRISTIAN O | Director | 10,500 | $9.77 | $102.6K | 1 |
| 2025-03-07 | Sell | BOLNO PAUL | CEO | 169,025 | $9.57 | $1.6M | 1 |
| 2024-11-25 | Sell | BOLNO PAUL | CEO | 50,000 | $15.00 | $750.0K | 1 |
| 2024-11-15 | Sell | BOLNO PAUL | CEO | 51,234 | $14.32 | $733.7K | 1 |
| 2024-11-08 | Sell | Francis Chris | Other officer | 36,000 | $16.00 | $576.0K | 1 |
| 2024-10-16 | Sell | Francis Chris | Other officer | 208,836 | $13.67 | $2.9M | 4 |
| 2024-10-16 | Sell | BOLNO PAUL | CEO | 90,474 | $15.00 | $1.4M | 1 |
| 2024-09-27 | Buy | GSK plc | 10% owner | 2,791,930 | $8.00 | $22.3M | 1 |
| 2024-09-25 | Sell | Moran Kyle | CFO | 17,146 | $9.00 | $154.3K | 1 |
| 2024-08-21 | Sell | BOLNO PAUL | CEO | 48,366 | $5.78 | $279.6K | 1 |
| 2024-04-03 | Sell | Moran Kyle | CFO | 15,630 | $6.17 | $96.4K | 1 |
| 2023-12-11 | Buy | Kolchinsky Peter | Director | 1,000,000 | $5.00 | $5.0M | 1 |
| 2023-12-07 | Buy | GSK plc | 10% owner | 3,300,000 | $5.00 | $16.5M | 1 |
| 2023-08-23 | Sell | Moran Kyle | CFO | 37,062 | $4.75 | $176.0K | 1 |
| 2023-02-16 | Sell | BOLNO PAUL | CEO | 29,400 | $4.04 | $118.8K | 1 |
| 2023-02-16 | Sell | Francis Chris | Other officer | 10,258 | $4.03 | $41.3K | 1 |
| 2023-02-16 | Sell | Vargeese Chandra | Other officer | 10,249 | $4.03 | $41.3K | 1 |
| 2023-02-16 | Sell | Moran Kyle | CFO | 9,729 | $4.04 | $39.3K | 1 |
| 2022-06-16 | Buy | Kolchinsky Peter | Director | 9,480,052 | $2.15 | $20.4M | 1 |
| 2022-05-05 | Sell | BOLNO PAUL | CEO | 33,501 | $1.72 | $57.6K | 1 |
| 2022-05-05 | Sell | Panzara Michael A. | Other officer | 16,714 | $1.72 | $28.7K | 1 |
| 2022-05-05 | Sell | Vargeese Chandra | Other officer | 16,714 | $1.72 | $28.7K | 1 |
| 2022-05-05 | Sell | Francis Chris | Other officer | 10,867 | $1.72 | $18.7K | 1 |
| 2022-05-05 | Sell | Moran Kyle | CFO | 5,021 | $1.72 | $8.6K | 1 |
| 2022-02-16 | Sell | BOLNO PAUL | CEO | 33,150 | $2.32 | $76.9K | 1 |
| 2022-02-16 | Sell | Vargeese Chandra | Other C-suite | 10,603 | $2.32 | $24.6K | 1 |
| 2022-02-16 | Sell | Panzara Michael A. | Other officer | 10,603 | $2.31 | $24.5K | 1 |
| 2022-02-16 | Sell | Francis Chris | Other officer | 10,123 | $2.31 | $23.4K | 1 |
| 2022-02-16 | Sell | Moran Kyle | CFO | 9,204 | $2.31 | $21.3K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Kolchinsky Peter | Director | $80.0M | $0 | 2026-03-30 |
| GSK plc | 10% owner | $66.8M | $0 | 2025-12-11 |
| Francis Chris | Other officer | $0 | $10.6M | 2026-02-26 |
| BOLNO PAUL | CEO | $0 | $7.3M | 2026-02-09 |
| Moran Kyle | CFO | $0 | $4.6M | 2026-02-09 |
| Tan Aik Na | Director | $0 | $1.8M | 2026-08-11 |
| HENRY CHRISTIAN O | Director | $0 | $1.6M | 2025-12-08 |
| Rawcliffe Adrian | Director | $0 | $806.6K | 2026-08-12 |
| Verdine Gregory L. | Director | $0 | $578.0K | 2025-12-08 |
| Wagner Heidi L | Director | $0 | $231.1K | 2026-08-11 |
| CORRIGAN MARK | Director | $0 | $217.3K | 2025-12-08 |
| Vargeese Chandra | Other officer | $0 | $138.1K | 2026-02-09 |
| TAKANASHI KEN | Director | $0 | $65.9K | 2026-08-11 |
| Panzara Michael A. | Other officer | $0 | $53.2K | 2022-05-05 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.